CLINICAL AND LABORATORY FEATURES OF EARLY AND LATE NEONATAL SEPSIS COURSE AT THE STAGE OF OBSTETRIC INSTITUTIONS
Neonatal sepsis (NS) is the leading cause of morbidity and mortality in intensive care units. The issue of early diagnosis of a purulent-septic process in newborns using modern research methods that can be used as screening methods for verifying the diagnosis remains relevant.
Objective. To conduct a comparative analysis of clinical and laboratory features of the course of early and late neonatal sepsis to optimize the early diagnosis of infectious-inflammatory process at the stage of obstetric institutions.
Material and methods. To achieve this goal, retrospectively 26 medical records of newborns at the stage of obstetric institutions were analyzed, which were later transferred for treatment to the Regional Municipal Non-Profit Enterprise "Chernivtsi Regional Children's Clinical Hospital" in Chernivtsi with manifestations of generalized infectious-inflammatory process. The first group consisted of 14 (53.8%) newborns diagnosed with early neonatal sepsis; the second group included 12 (46.2%) newborns that were diagnosed with late neonatal sepsis (p > 0.05).
Research results. Peculiarities of the clinical manifestation of the infectious-inflammatory process should be recognized as a combination of several locus of infection, which occurred in group I in 57.1% of cases, in group II – in 16.6% of cases (p < 0.05). Muffled heart sounds at the initial examination and a tendency to thermolability were more common in newborns with early NS: OR – 6.1 (95% CI 2.71–13.92), RR – 1.97 (95% CI 0.97–3.97), AR – 0.39 and OR – 3.6 (95% CI 2.01–6.46), RR – 1.89 (95% CI 1.38–2.58), AR – 0.31.
Conclusion. The analysis revealed that in early neonatal sepsis the risk of detecting muffled heart sounds during auscultation (odds ratio – 6.1), unstable body temperature (odds ratio – 3.6) and absolute leukocyte count > 20.0×109/L is significantly higher (odds ratio – 2.79).
2. Anderson–Berry AL, Bellig LL, Ohning BL, Rosenkrantz T et al. Neonatal Sepsis. Medscape Video NEW Clinical. Cited 2017 Sept 19. Retrieved from: http://emedicine.medscape.com/article/978352-overview
3. Surkov DN, Surkova AD. & Ivanov DO. [Epidemiology of neonatal sepsis: analysis of the neonatal intensive care unit]. Vestnik sovremennoy klinicheskoy meditsinyi. 2014;7(6):56-61.
4. Malloy MH. Chorioamnionitis: epidemiology of newborn management and outcome United States 2008. Journal of Perinatology. 2014.
5. Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–80.
6. Satar M, Engin Arısoy A, Çelik İH. Turkish Neonatal Society guideline on neonatal infections - diagnosis and treatment. Turk Pediatri Ars. 2018;53(1):88-100
7. Guzick DS, Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol. 1985;65:11–6.
8. Muhin VE, Pankrateva LL. and Volodin NN. [Neonatal sepsis: problems of laboratory verification of the diagnosis]. Pediatriya. Zhurnal im. G. N. Speranskogo. 2018;97(1):141-146.
9. Levy MM, Fink JP, Marshall et al. International Sepsis Definitions Conference. Int. Care Med. 2003;29:530-538.
10. Klymenko TM, Kosenko KO. Predicting the course of early onset neonatal sepsis in pretern infants. Modern Pediatrics. 2019;8(104):1923.
11. Juanzhen Li, Botao Ning, Ying Wang, Biru Li, Juan Qian, Hong Ren, Jian Zhang, Xiaowei Hu.The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis. Medicine (Baltimore). 2019;98(13): e15070
12. Jain A, Sankar J, Anubhuti A, Yadav DK, Sankar MJ. Prevalence and outcome of sepsisinduced myocardial dysfunction in children with ‘Sepsis’ ‘With’ and ‘Without Shock’-aprospective observational study. J Trop Pediatr. 2018;64(6):501–509.
13. Kissoon N, Reinhart K, Daniels R, Machado MFR, Schachter RD, Finfer S. Sepsis in Children: Global Implications of the World Health Assembly Resolution on Sepsis. Pediatr Crit Care Med. 2017;18(12):e625-e627.
14. Kucherov YU, Jirkova YV, Chebotaeva LI, Shishkina TN. [Laboratory markers for early diagnosis of neonatal sepsis]. Anesteziologiya i reanimatologiya. 2015;3:11-15.
15. Report of the Expert Meeting on Neonatal and Paediatric Sepsis/European Medicines Agency. London, 2010. 6 p. EMA/477725/2010.
16. Odabasi IO, Bulbul A. Neonatal Sepsis. Sisli Etfal Hastan Tip Bul. 2020;54(2):142-158.
17. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in early onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102:25–36.
18. Arnon S, Litmanovitz I. Diagnostic tests in neonatal sepsis. Curr Opin Infect Dis. 2008;21:223–7.
19. Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J. 2012;31:16–9.
This work is licensed under a Creative Commons Attribution 4.0 International License.